Monday, March 20, 2023

Informa Connect’s Annual Life Sciences Commercial Contracts & Chargebacks Congress

Informa Connect’s Annual Life Sciences Commercial Contracts & Chargebacks Congress
May 16-17, 2023
The Omni Shoreham Hotel | Washington, DC
Hybrid Event

Exclusive Offer for Drug Channels Readers: Register Now to SAVE 10%* using promo code 23DC10

Informa Connect’s 19th Annual Commercial Contracts & Chargebacks Congress, taking place May 16-17 in Washington, DC, offers crucial updates on policy changes and contracting best practices to increase efficiency, reduce revenue leakage, and streamline chargeback excellence. This annual event has become a must-attend for pricing and contracting professionals in the life sciences industry with seasoned leaders and forward-thinking strategies on display. Join industry stakeholders, including manufacturers, wholesalers, GPOs and more, for a robust two-day event offering extended content and actionable strategies in key interest areas in the ever-evolving contracting landscape.

Featured Faculty Driving the Conversation:
  • Rosalind Davis, Government Pricing & Contracts Director, Vifor Pharma, Inc.
  • Stephani Kupski, Director, U.S. Pricing & Government Reporting, CSL Behring
  • Mallory O’Connor, Public Policy Executive Director, Mallinckrodt
  • Cad Snyder, Director, Global Finance Shared Services, Cardinal Health
  • Beth Stevens, Associate Director, Contracts and Pricing, Tolmar Inc.
  • Roxana Santiago, Director Controlling Revenue Accounting, Fresenius Kabi USA LLC
  • Jennifer Plemmons Crosswell, Director, Contracts & Pricing, Accounting, Azurity Pharmaceuticals
  • Mitesh Ghia, Director, Chargebacks, Membership, Rebates & Contract Administration, Novartis Pharmaceuticals Corporations
  • Elizabeth Johnson, President, National Association of Medication Access & Patient Advoacacy
  • Erika Chiles-George, Pricing & Trade Director, Contracts, Neurocrine Biosciences
  • And many more!
Hight Impact Topics Transforming the Market Include:
  • Commercial Contract Model Landscape
  • Assessing the Impact of IRA on Product Calculations
  • 340B Drug Discount Program — Ongoing Monitoring of 340B Program Risks & Best Practices
  • Multi-Stakeholder Panel — Membership and Class of Trade
  • Updated Review and Interpretation of the Inflation Reduction Act
  • GTN Forecasting Across Different Channels
  • PLUS! — Customize Your Learning by Choosing Between Two Thought-Provoking Tracks:
    • Contracts and Chargebacks Excellence
    • Analytical and Technology Innovation
  • and more!
NEW THIS YEAR! The 2023 Summit is Part of Life Sciences Pricing & Contracting USA Uniting three industry leading events — Medicaid & Government Pricing Congress, Drug Pricing Transparency Congress and Life Sciences Commercial Contracts & Chargebacks — Life Sciences Pricing & Contracting USA is the industry’s go-to resource for gaining critical insight on regulatory requirements, policy initiatives and best practices to enhance pricing and contracting models. Attend your preferred event and prepare for critical content tailored to your focus area, plus benefit from a more diverse speaking faculty and greater networking opportunities to expand your network and establish powerful partnerships.


Attendees of Commercial Contracts & Chargebacks 2023 have the option to add a third day of content to their schedule and join the Medicaid & Government Pricing Congress attendees for their final day. Benefit from a fireside chat, in-depth sessions and learning streams, plus additional networking opportunities!

Drug Channels readers are eligible for an exclusive savings of 10% off* the standard rate by using promo code 23DC10, so download the complete conference agenda and reserve your seat today!

*Expires 5/16/2023; applies to current rate only and may not be combined or applied to existing registrations; other restrictions may apply

The content of Sponsored Posts does not necessarily reflect the views of Pembroke Consulting, Inc., Drug Channels, or any of its employees. To find out how you can promote an event on Drug Channels, please contact Paula Fein (

No comments:

Post a Comment